Kenvue Inc (KVUE)

$17.12 +0.11 (0.65%)
Market Cap 32.59B
Revenue (ttm) 15.46B
Net Income (ttm) 1.03B
EPS (ttm) N/A
PE Ratio 15.89
Forward PE 15.57
Profit Margin 6.66%
Debt to Equity Ratio 0.66
Volume 47,245,600
Avg Vol 42,010,277
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 65%
Beta 0.60
Analysts Sell
Price Target $19.00

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment...

Industry: Household & Personal Products
Sector: Consumer Defensive
Address:
1 Kenvue Way, Summit, United States
Suite510
Suite510 Jan. 15 at 4:46 AM
$JNJ $KVUE At stake: the major plaintiff-side firm’s cut of potentially $22 billion in claims brought by vaginal cancer patients who accused the health-care giant of selling asbestos-tainted talc products. JNJ lol 😂 I said 30B, i’m pretty close 🍿
0 · Reply
Bazzzigar
Bazzzigar Jan. 14 at 9:11 PM
$KVUE CALM
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 14 at 7:33 PM
$JNJ $KVUE Wrong again!!! You are my favorite moron. You have no idea what you’re talking about and constantly post complete garbage. Does it suck being wrong every single day?
0 · Reply
DragonAlgo
DragonAlgo Jan. 14 at 9:29 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-01-16 | Strike: $17.00 | Type: CALL Option Plan (premium): Entry: $0.25 Stop: $0.18 TP1: $0.33 TP2: $0.42 TP3: $0.60 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Jan. 14 at 1:15 AM
$JNJ $KVUE J&J's strategy of using bankruptcy to resolve the massive talc lawsuits has failed. The focus is back on courtroom battles, with significant verdicts (like a December 2025 $1.5 billion mesothelioma award) adding pressure, lol 😂 “under pressure” One of David Bowie greatest hits
1 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 13 at 8:23 PM
$JNJ $KVUE My popcorn tastes great!!! It feels good to know I made money today and your busted ass can’t afford popcorn of your own. Getting your investment advice from obscure YouTube sources while sitting in mommy and daddy’s basement is really paying off!!! Nailed it!!!
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 13 at 8:18 PM
$JNJ $KVUE Nailed it again! Nice work professor!
0 · Reply
Suite510
Suite510 Jan. 13 at 7:02 PM
$JNJ $KVUE Popcorn 🍿 just waiting to pop 🙈 https://youtu.be/ufbGyeRmJHs?si=86ijZzBfmoiUrhQC
0 · Reply
DragonAlgo
DragonAlgo Jan. 13 at 1:11 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-01-16 | Strike: $17.00 | Type: CALL Option Plan (premium): Entry: $0.28 Stop: $0.20 TP1: $0.36 TP2: $0.48 TP3: $0.67 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Jan. 13 at 12:52 PM
$JNJ $KVUE Get the popcorn 🍿 ready 😂👋🙈 Massive J&J verdicts set stage for 2026 talc litigants Company reels from Baltimore jury's $1.5B award Pat Murphy // January 12, 2026 // 7 Minute Read
0 · Reply
Latest News on KVUE
Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 14 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR

Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 18 days ago

Best Dividend Kings: December 2025

ABBV ABM ABT ADM ADP AWR BDX

Dividend Kings: 3 Ideal Buys In 56 For December

Dec 11, 2025, 5:50 PM EST - 4 weeks ago

Dividend Kings: 3 Ideal Buys In 56 For December

MO UBSI

GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities

Dec 9, 2025, 9:50 PM EST - 5 weeks ago

GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities

ACN DHI HON JNJ ORCL SSB WFC

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

Dec 9, 2025, 10:15 AM EST - 5 weeks ago

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

AES AMCR ARE CAG CPB D DOC

Macquarie Value Fund Q3 2025 Contributors And Detractors

Dec 7, 2025, 2:06 PM EST - 5 weeks ago

Macquarie Value Fund Q3 2025 Contributors And Detractors

EA FIS GOOG GOOGL

Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out

Dec 5, 2025, 1:36 PM EST - 5 weeks ago

Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out

American Century Value Fund Q3 2025 Contributors/Detractors And Notable Trades

Dec 1, 2025, 1:36 PM EST - 6 weeks ago

American Century Value Fund Q3 2025 Contributors/Detractors And Notable Trades

BWA CNC CRM JNJ LMT NVT TER

Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 6 weeks ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR

American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades

Nov 20, 2025, 12:55 PM EST - 7 weeks ago

American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades

BKR CHTR CNC HOOD HSIC IPG PCAR

US appeals court to weigh reviving cases over Tylenol and autism

Nov 17, 2025, 6:07 AM EST - 2 months ago

US appeals court to weigh reviving cases over Tylenol and autism

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Nov 14, 2025, 12:42 PM EST - 2 months ago

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Nov 14, 2025, 6:05 AM EST - 2 months ago

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 2 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Watch These Stocks Falling 10% Or More

Nov 4, 2025, 4:58 PM EST - 2 months ago

Watch These Stocks Falling 10% Or More

AJG ARE BAX BRO CAVA CMG DECK

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

Nov 4, 2025, 2:26 PM EST - 2 months ago

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

IYK KMB VDC XLP

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

Nov 3, 2025, 10:00 PM EST - 2 months ago

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

KMB

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

Nov 3, 2025, 7:11 PM EST - 2 months ago

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

KMB

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Nov 3, 2025, 6:40 PM EST - 2 months ago

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

KMB

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

Nov 3, 2025, 5:20 PM EST - 2 months ago

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

KMB

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

Nov 3, 2025, 5:15 PM EST - 2 months ago

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

AMZN KMB

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

Nov 3, 2025, 4:58 PM EST - 2 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

KMB

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

Nov 3, 2025, 4:39 PM EST - 2 months ago

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

KMB

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

Nov 3, 2025, 4:01 PM EST - 2 months ago

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

KMB

Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 2 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

Nov 3, 2025, 12:37 PM EST - 2 months ago

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

KMB

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Nov 3, 2025, 12:01 PM EST - 2 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

KMB

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Nov 3, 2025, 11:40 AM EST - 2 months ago

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

KMB

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 2 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Nov 3, 2025, 10:44 AM EST - 2 months ago

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

KMB

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

Nov 3, 2025, 10:33 AM EST - 2 months ago

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

KMB

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

Nov 3, 2025, 9:57 AM EST - 2 months ago

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

KMB

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Nov 3, 2025, 9:30 AM EST - 2 months ago

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Nov 3, 2025, 9:16 AM EST - 2 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

KMB

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

Nov 3, 2025, 9:15 AM EST - 2 months ago

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

KMB

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

Nov 3, 2025, 8:40 AM EST - 2 months ago

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

KMB

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

Nov 3, 2025, 8:27 AM EST - 2 months ago

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

KMB

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

Nov 3, 2025, 8:24 AM EST - 2 months ago

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

KMB

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

Nov 3, 2025, 7:49 AM EST - 2 months ago

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

KMB

Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion

Nov 3, 2025, 6:50 AM EST - 2 months ago

Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion

KMB

Kimberly-Clark to Buy Tylenol Maker Kenvue

Nov 3, 2025, 6:44 AM EST - 2 months ago

Kimberly-Clark to Buy Tylenol Maker Kenvue

KMB

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

Nov 3, 2025, 6:36 AM EST - 2 months ago

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

KMB

Kenvue Reports Third Quarter 2025 Results

Nov 3, 2025, 6:30 AM EST - 2 months ago

Kenvue Reports Third Quarter 2025 Results

Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader

Nov 3, 2025, 6:30 AM EST - 2 months ago

Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader

KMB

Kenvue: Temporary Headwinds Don't Derail Its Consumer Health Dominance And 5.5% Dividend Yield

Oct 29, 2025, 2:30 PM EDT - 2 months ago

Kenvue: Temporary Headwinds Don't Derail Its Consumer Health Dominance And 5.5% Dividend Yield

US health chief says not enough data to show Tylenol causes autism, but still advises caution

Oct 29, 2025, 2:08 PM EDT - 2 months ago

US health chief says not enough data to show Tylenol causes autism, but still advises caution

Suite510
Suite510 Jan. 15 at 4:46 AM
$JNJ $KVUE At stake: the major plaintiff-side firm’s cut of potentially $22 billion in claims brought by vaginal cancer patients who accused the health-care giant of selling asbestos-tainted talc products. JNJ lol 😂 I said 30B, i’m pretty close 🍿
0 · Reply
Bazzzigar
Bazzzigar Jan. 14 at 9:11 PM
$KVUE CALM
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 14 at 7:33 PM
$JNJ $KVUE Wrong again!!! You are my favorite moron. You have no idea what you’re talking about and constantly post complete garbage. Does it suck being wrong every single day?
0 · Reply
DragonAlgo
DragonAlgo Jan. 14 at 9:29 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-01-16 | Strike: $17.00 | Type: CALL Option Plan (premium): Entry: $0.25 Stop: $0.18 TP1: $0.33 TP2: $0.42 TP3: $0.60 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Jan. 14 at 1:15 AM
$JNJ $KVUE J&J's strategy of using bankruptcy to resolve the massive talc lawsuits has failed. The focus is back on courtroom battles, with significant verdicts (like a December 2025 $1.5 billion mesothelioma award) adding pressure, lol 😂 “under pressure” One of David Bowie greatest hits
1 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 13 at 8:23 PM
$JNJ $KVUE My popcorn tastes great!!! It feels good to know I made money today and your busted ass can’t afford popcorn of your own. Getting your investment advice from obscure YouTube sources while sitting in mommy and daddy’s basement is really paying off!!! Nailed it!!!
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 13 at 8:18 PM
$JNJ $KVUE Nailed it again! Nice work professor!
0 · Reply
Suite510
Suite510 Jan. 13 at 7:02 PM
$JNJ $KVUE Popcorn 🍿 just waiting to pop 🙈 https://youtu.be/ufbGyeRmJHs?si=86ijZzBfmoiUrhQC
0 · Reply
DragonAlgo
DragonAlgo Jan. 13 at 1:11 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-01-16 | Strike: $17.00 | Type: CALL Option Plan (premium): Entry: $0.28 Stop: $0.20 TP1: $0.36 TP2: $0.48 TP3: $0.67 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Jan. 13 at 12:52 PM
$JNJ $KVUE Get the popcorn 🍿 ready 😂👋🙈 Massive J&J verdicts set stage for 2026 talc litigants Company reels from Baltimore jury's $1.5B award Pat Murphy // January 12, 2026 // 7 Minute Read
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 12 at 11:19 PM
$JNJ $KVUE I’m American you third world reject. Stop asking ChatGPT for market analysis. It has as much knowledge of the legal system as your dumb ass. Stop posting garbage on stocks in which you don’t own a position. Your life will be much better when you’re not watching other people make money on positions that are the exact opposite of your “predictions.”
0 · Reply
OptionSamurai
OptionSamurai Jan. 12 at 4:05 PM
A new candidate for a wheel strategy on our screener: $KVUE 💵 Company has a fundamental score of 6 and a growth score of 7. 📈 IV percentile is 42.5% 🔮 Annualized covered call return is 25.9% You can sell a put strike 16.0 (3.7 ATRs away) for 30-Jan-26 ✅ Return is 1.3% and 25.4% annualized ✅ Breakeven is 7.7% away ✅ Dividend yield if assigned is 4.9% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Suite510
Suite510 Jan. 12 at 2:34 AM
$JNJ $KVUE $MSTR $BTC.X Owning JNJ above $200 a share with billions upon billions in Talc Liability is like owning Micro Strategy above $500 lol 😂 good luck Cheers 🥂
0 · Reply
Suite510
Suite510 Jan. 12 at 2:25 AM
$JNJ $KVUE Sure retarded Euro trash nut this: In Summary: J&J is indeed losing many talc lawsuits, with major verdicts and failed bankruptcy attempts in 2025-2026, resulting in large payouts and continued legal challenges 🤣🙈 PT $155 time to pay up JNJ for 50 years of Talc Liability, why do you think they surrender to Trump Tariffs idiot, shit going to hit the fans soon like Euro AC
0 · Reply
creedog
creedog Jan. 11 at 7:32 PM
$KVUE what do they do
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 11 at 6:13 AM
$JNJ $KVUE No tariffs to go along with no money paid in lawsuits. Still grasping at straws. Move along bot.
0 · Reply
DragonAlgo
DragonAlgo Jan. 11 at 1:21 AM
🐉 $KVUE CALL — DragonAlgo® VIP Signal 🚀 If it breaks clean, it can run quicker than people expect. 📄 Contract: KVUE 2026-01-16 C18 🗓 Expiry: 2026-01-16 | 🎯 Strike: 17.50 | 🧭 Type: CALL 💎 Option Plan (premium): 🟡 Entry: 0.08 🛑 Stop: 0.05 🎯 TP1: 0.10 🏁 TP2: 0.13 🚀 TP3: 0.18 ⏳ Alerts like this don’t sit still. ⚠️ Educational only — not financial advice. 🔗 https://dragonalgo.com
0 · Reply
Bazzzigar
Bazzzigar Jan. 9 at 11:25 PM
$KVUE HIMS...
0 · Reply
ValueInvesting21
ValueInvesting21 Jan. 9 at 4:07 PM
$KVUE fact is, this won't do well while other in-demand tech stocks are ripping higher. No one wants these tiny gains these days.
0 · Reply
Suite510
Suite510 Jan. 9 at 12:27 PM
$JNJ $KVUE Reduced drug prices due to the Trump surrender agreement, plus talc billion dollar verdicts 🥵🤣
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Jan. 9 at 4:46 AM
$JNJ $KVUE The dumbest of the bots with another irrelevant post.
0 · Reply
Valuation_Finance
Valuation_Finance Jan. 9 at 3:16 AM
$KVUE It is narrowing because KVUE rose more than KMB even though KMB hit a 5-year low. You fail to grasp that KVUE could approach the proposed merger price by recovering faster from a drawdown affecting the industry than the acquiror: $3.50 is a hurdle; $KMB x 14.625% gets smaller if KMB rises less than KVUE. You need 2 brain cells to grasp that.
1 · Reply